Stay updated on Early Ixekizumab Activity in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Early Ixekizumab Activity in Psoriasis Clinical Trial page.

Latest updates to the Early Ixekizumab Activity in Psoriasis Clinical Trial page
- Check6 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded the site revision tag Revision: v3.4.2. Removed the prior government funding notice and Revision: v3.4.1.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page now displays a government funding notice banner about potential delays and updates, and the site version has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedA glossary feature was added to the page. Other changes are small text/case tweaks (QC criteria wording) and a revision update to v3.4.0, with the old v3.3.4 noted.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page shows a new revision label v3.3.4 replacing v3.3.3; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedA Locations section is added that lists New York as a study site, replacing the former New York Locations entry. The HHS Vulnerability Disclosure section is removed and the revision label updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Early Ixekizumab Activity in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Ixekizumab Activity in Psoriasis Clinical Trial page.